Origen de la red de primer grado Brett Newswanger.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
ClostraBio, Inc.
 ClostraBio, Inc. BiotechnologyHealth Technology ClostraBio, Inc. develops microbiome-modulating therapeutics. It creates a drug that aims to prevent allergic reactions to food. The firm is dedicated to understanding and treating food allergies and other diseases of the immune system. The company was founded by Cathryn R. Nagler and Jeffrey A. Hubbell and is headquartered in Chicago, IL.
4
| Holding Company | Biotechnology | 4 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Brett Newswanger a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
MediChem Life Sciences, Inc.
 MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Miscellaneous Commercial Services | President | |
| University of Notre Dame | College/University | Undergraduate Degree | |
Endotronix, Inc.
 Endotronix, Inc. Medical SpecialtiesHealth Technology Endotronix, Inc. develops wireless heart sensor technology. The firm has introduced the Cordella Heart Failure System, a comprehensive solution for heart failure management. The company was founded by Anthony I. Nunez and Harry D. Rowland in June 2007 and is headquartered in Lisle, IL. | Medical Specialties | Director of Finance/CFO | |
| École Polytechnique Fédérale de Lausanne | College/University | Corporate Officer/Principal | |
Emerald BioStructures, Inc.
 Emerald BioStructures, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Beryllium LLC, Emerald BioStructures, Inc. is a company that offers products and services in protein X-ray crystallography, specializing in the area of protein crystallization. The company is based in Bainbridge Island, WA. The company was founded by Lance K. Stewart. Emerald BioStructures was acquired by MediChem Research, Inc. on May 31, 2000. | Miscellaneous Commercial Services | President | |
| The University of Texas at Austin | College/University | Corporate Officer/Principal | |
| Lewis University | College/University | Masters Business Admin | |
| Marquette University | College/University | Undergraduate Degree | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Corporate Officer/Principal | |
| Flavin Ventures LLC | Corporate Officer/Principal | ||
| Swiss Federal Institute of Technology | College/University | Corporate Officer/Principal | |
| Advanced X-Ray Analytical Services, Inc. | President | ||
Anokion SA
 Anokion SA Medical/Nursing ServicesHealth Services Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland. | Medical/Nursing Services | Founder | |
Kanyos Bio, Inc.
 Kanyos Bio, Inc. Pharmaceuticals: MajorHealth Technology Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
Levo Therapeutics, Inc.
 Levo Therapeutics, Inc. BiotechnologyHealth Technology Levo Therapeutics, Inc. operates as a pharmaceutical company. The company is headquartered in Glenview, IL. | Biotechnology | Corporate Officer/Principal | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Founder Chief Operating Officer | |
Portal Innovations LLC
 Portal Innovations LLC Investment ManagersFinance Portal Innovations LLC (Portal Innovations) is a venture capital firm founded in 2020 by John L. Flavin. The firm is headquartered in Chicago, Illinois. | Investment Managers | Chief Executive Officer Private Equity Investor |
Estadísticas
Internacional
| Estados Unidos | 18 |
| Suiza | 5 |
Sectorial
| Health Technology | 8 |
| Consumer Services | 8 |
| Commercial Services | 4 |
| Health Services | 2 |
| Finance | 2 |
Operativa
| Director/Board Member | 7 |
| Corporate Officer/Principal | 7 |
| Founder | 7 |
| President | 6 |
| Chairman | 4 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| John Flavin | 12 |
| Jeffrey A. Hubbell | 8 |
| Ritu Shah | 6 |
| Cathryn R. Nagler | 1 |
- Bolsa de valores
- Insiders
- Brett Newswanger
- Conexiones Empresas
